CA Stock MarketDetailed Quotes

NSHS Nanosphere Health Sciences Inc

Watchlist
  • 0.045
  • 0.0000.00%
15min DelayMarket Closed Dec 24 11:51 ET
462.38KMarket Cap-3.21P/E (TTM)

Nanosphere Health Sciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-76.99%-47.41K
334.01%18.25K
137.57%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.63%4.21K
-325.30%-21.25K
-4.61%-67.66K
180.48%15.87K
Net income from continuing operations
-0.63%-41.74K
21.87%-61.06K
22.90%-41.29K
19.03%-228.13K
41.24%-54.94K
-17.80%-41.48K
5.99%-78.15K
23.40%-53.56K
20.92%-281.75K
-149.87%-93.5K
Operating gains losses
-526.59%-19.01K
368.54%12.5K
7,693.89%29.84K
-163.01%-27.45K
-268.25%-26.86K
-79.91%4.46K
-142.84%-4.66K
92.78%-393
172.74%43.57K
137.66%15.96K
Remuneration paid in stock
--0
--0
--0
-69.74%2.99K
-100.22%-3
-84.88%247
-59.54%1.38K
-60.38%1.36K
-57.63%9.88K
-59.22%1.39K
Other non cashItems
--830
----
----
----
----
----
----
---20
----
----
Change In working capital
25.84%12.56K
-22.39%66.45K
-38.00%19.43K
23.80%198.89K
-21.82%71.94K
136.18%9.98K
192.31%85.63K
-53.18%31.34K
-51.05%160.65K
154.70%92.02K
-Change in receivables
-5,963.23%-31.17K
2,022.72%29.88K
-108.79%-1.14K
-10.27%-3.62K
-19.95%-1K
-61.64%-514
-13.10%-1.55K
27.39%-546
-417.31%-3.28K
-380.87%-837
-Change in payables and accrued expense
316.55%43.73K
-58.05%36.57K
-35.48%20.57K
23.53%202.51K
-21.44%72.94K
136.87%10.5K
205.31%87.18K
-55.09%31.89K
-49.89%163.93K
155.10%92.86K
Cash from discontinued investing activities
Operating cash flow
-76.76%-47.35K
331.95%18.25K
137.53%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.68%4.23K
-325.70%-21.27K
-4.61%-67.66K
180.48%15.87K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
-13.39%22.68K
-75.81%8.13K
-83.07%9.32K
-57.93%55.01K
-81.29%11.37K
-70.39%26.19K
-73.00%33.6K
-57.93%55.01K
909.86%130.76K
-59.20%60.75K
Current changes in cash
38.13%-16.57K
331.95%18.25K
137.53%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.68%4.23K
-325.70%-21.27K
-157.46%-67.66K
204.54%15.87K
Effect of exchange rate changes
-52.34%5.7K
68.25%-3.69K
-6,270.83%-9.17K
198.99%8K
136.14%7.81K
5.98%11.97K
-427.79%-11.63K
89.04%-144
-12,934.92%-8.09K
-631.12%-21.61K
End cash Position
3.91%11.81K
-13.39%22.68K
-75.81%8.13K
-83.07%9.32K
-83.07%9.32K
-81.29%11.37K
-70.39%26.19K
-73.00%33.6K
-57.93%55.01K
-57.93%55.01K
Free cash from
-76.76%-47.35K
331.95%18.25K
137.53%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.68%4.23K
-325.70%-21.27K
-4.61%-67.66K
180.48%15.87K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -76.99%-47.41K334.01%18.25K137.57%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.63%4.21K-325.30%-21.25K-4.61%-67.66K180.48%15.87K
Net income from continuing operations -0.63%-41.74K21.87%-61.06K22.90%-41.29K19.03%-228.13K41.24%-54.94K-17.80%-41.48K5.99%-78.15K23.40%-53.56K20.92%-281.75K-149.87%-93.5K
Operating gains losses -526.59%-19.01K368.54%12.5K7,693.89%29.84K-163.01%-27.45K-268.25%-26.86K-79.91%4.46K-142.84%-4.66K92.78%-393172.74%43.57K137.66%15.96K
Remuneration paid in stock --0--0--0-69.74%2.99K-100.22%-3-84.88%247-59.54%1.38K-60.38%1.36K-57.63%9.88K-59.22%1.39K
Other non cashItems --830---------------------------20--------
Change In working capital 25.84%12.56K-22.39%66.45K-38.00%19.43K23.80%198.89K-21.82%71.94K136.18%9.98K192.31%85.63K-53.18%31.34K-51.05%160.65K154.70%92.02K
-Change in receivables -5,963.23%-31.17K2,022.72%29.88K-108.79%-1.14K-10.27%-3.62K-19.95%-1K-61.64%-514-13.10%-1.55K27.39%-546-417.31%-3.28K-380.87%-837
-Change in payables and accrued expense 316.55%43.73K-58.05%36.57K-35.48%20.57K23.53%202.51K-21.44%72.94K136.87%10.5K205.31%87.18K-55.09%31.89K-49.89%163.93K155.10%92.86K
Cash from discontinued investing activities
Operating cash flow -76.76%-47.35K331.95%18.25K137.53%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.68%4.23K-325.70%-21.27K-4.61%-67.66K180.48%15.87K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position -13.39%22.68K-75.81%8.13K-83.07%9.32K-57.93%55.01K-81.29%11.37K-70.39%26.19K-73.00%33.6K-57.93%55.01K909.86%130.76K-59.20%60.75K
Current changes in cash 38.13%-16.57K331.95%18.25K137.53%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.68%4.23K-325.70%-21.27K-157.46%-67.66K204.54%15.87K
Effect of exchange rate changes -52.34%5.7K68.25%-3.69K-6,270.83%-9.17K198.99%8K136.14%7.81K5.98%11.97K-427.79%-11.63K89.04%-144-12,934.92%-8.09K-631.12%-21.61K
End cash Position 3.91%11.81K-13.39%22.68K-75.81%8.13K-83.07%9.32K-83.07%9.32K-81.29%11.37K-70.39%26.19K-73.00%33.6K-57.93%55.01K-57.93%55.01K
Free cash from -76.76%-47.35K331.95%18.25K137.53%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.68%4.23K-325.70%-21.27K-4.61%-67.66K180.48%15.87K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data